Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,456 | 2,971 | -49,048 | -4,762 | -2,897 |
| Depreciation Amortization | 45 | 66 | 50 | 40 | 29 |
| Income taxes - deferred | N/A | N/A | -13,582 | -1,459 | -973 |
| Accounts receivable | -914 | -1,078 | N/A | N/A | N/A |
| Other Working Capital | -547 | -925 | 117 | -71 | -210 |
| Other Operating Activity | 950 | 984 | 54,173 | -68 | -120 |
| Operating Cash Flow | $990 | $2,018 | $-8,290 | $-6,320 | $-4,171 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -29 | -25 | -28 | -13 | -5 |
| Other Investing Activity | 0 | 0 | 1,400 | 1,400 | 1,400 |
| Investing Cash Flow | $-29 | $-25 | $1,372 | $1,387 | $1,395 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1,000 | 1,000 | 1,000 |
| Common Stock Issued | 3,928 | 3,928 | 7,912 | 7,869 | 7,869 |
| Other Financing Activity | -117 | -52 | -19 | 0 | 0 |
| Financing Cash Flow | $3,811 | $3,876 | $8,893 | $8,869 | $8,869 |
| Beginning Cash Position | 2,752 | 2,752 | 777 | 777 | 777 |
| End Cash Position | 7,524 | 8,621 | 2,752 | 4,713 | 6,870 |
| Net Cash Flow | $4,772 | $5,869 | $1,975 | $3,936 | $6,093 |
| Free Cash Flow | |||||
| Operating Cash Flow | 990 | 2,018 | -8,290 | -6,320 | -4,171 |
| Capital Expenditure | -29 | -25 | -28 | -13 | -5 |
| Free Cash Flow | 961 | 1,993 | -8,318 | -6,333 | -4,176 |